organization · Reporting owner
Healthcare Partners IX, L.P.
Disclosed activity across 1 company
Sign in to followReported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
CYPHERPUNK TECHNOLOGIES INC.
Report date February 09, 2021 · Filed February 11, 2021
Jointly reported with HealthCare Ventures IX, L.P., Healthcare Partners IX, LLC
Section 16 reporting ended · disclosed 2021-02-11. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Warrant (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.95 · Expires 2026-02-05 | Direct | 0 |
Reported balance
After 2021-02-09 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2021-02-09 · Other · Disposed 571,428 · Balance 0 F1: On February 9, 2020, HealthCare Ventures IX, L.P. ("HCVIX") transferred, for no consideration, all 571,428 warrants to purchase common stock it held (the "Transfer") to the limited partners of HCVIX on a pro rata basis. The term of HCVIX expired on December 31, 2020, at which time HCVIX entered into liquidation. The process of liquidating HCVIX, including the distribution of marketable and non-marketable securities, has commenced in 2021, and HealthCare Partners IX, L.P. ("HCPIX"), the General Partner of HCVIX, as liquidator, will use its best efforts to complete the orderly liquidation of HCVIX. F2: These warrants were owned directly by HCVIX. Christopher K. Mirabelli, Douglas E. Onsi and Augustine Lawlor (collectively, the "HCVIX Directors") are the Managing Directors of HealthCare Partners IX, LLC ("HCPIX LLC"), which is the General Partner of HCPIX, which is the General Partner of HCVIX. Each of the HCVIX Directors, HCPIX LLC and HCPIX indirectly beneficially owns and shares voting and dispositive power with respect to all of the securities owned by HCVIX, and each disclaimed beneficial ownership of the warrants except to the extent of his or its proportionate pecuniary interest therein. F3: The warrants were acquired in connection with the purchase of an equal number of shares of common stock by the reporting persons on February 5, 2019 for $1.75 per share. Each such purchased share of common stock was issued with a warrant to purchase one share of common stock. HCVIX will continue to hold 4,144,804 shares of common stock following the Transfer. |
Filing footnotes · ownership attribution and instrument terms
F1: On February 9, 2020, HealthCare Ventures IX, L.P. ("HCVIX") transferred, for no consideration, all 571,428 warrants to purchase common stock it held (the "Transfer") to the limited partners of HCVIX on a pro rata basis. The term of HCVIX expired on December 31, 2020, at which time HCVIX entered into liquidation. The process of liquidating HCVIX, including the distribution of marketable and non-marketable securities, has commenced in 2021, and HealthCare Partners IX, L.P. ("HCPIX"), the General Partner of HCVIX, as liquidator, will use its best efforts to complete the orderly liquidation of HCVIX.
F2: These warrants were owned directly by HCVIX. Christopher K. Mirabelli, Douglas E. Onsi and Augustine Lawlor (collectively, the "HCVIX Directors") are the Managing Directors of HealthCare Partners IX, LLC ("HCPIX LLC"), which is the General Partner of HCPIX, which is the General Partner of HCVIX. Each of the HCVIX Directors, HCPIX LLC and HCPIX indirectly beneficially owns and shares voting and dispositive power with respect to all of the securities owned by HCVIX, and each disclaimed beneficial ownership of the warrants except to the extent of his or its proportionate pecuniary interest therein.
F3: The warrants were acquired in connection with the purchase of an equal number of shares of common stock by the reporting persons on February 5, 2019 for $1.75 per share. Each such purchased share of common stock was issued with a warrant to purchase one share of common stock. HCVIX will continue to hold 4,144,804 shares of common stock following the Transfer.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 09, 2021 Filed Feb 11, 2021 21:57 UTC | CYPHERPUNK TECHNOLOGIES INC. LPTX · Entity 6392 | OtherWarrant (Right to Buy) · Derivative | 571,428 | Not disclosed Strike: $1.95 | Not disclosed |
DisclosureSEC source: 0001104659-21-021029 · tm216410-1_4seq1.xml · derivative · entry 1 HealthCare Ventures IX, L.P. · CIK 0001490245 · 10% owner Healthcare Partners IX, L.P. · CIK 0001697027 · 10% owner Healthcare Partners IX, LLC · CIK 0001698828 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $0.001 par value per share · 571,428 shares Expires 2026-02-05 F1 · kind: On February 9, 2020, HealthCare Ventures IX, L.P. ("HCVIX") transferred, for no consideration, all 571,428 warrants to purchase common stock it held (the "Transfer") to the limited partners of HCVIX on a pro rata basis. The term of HCVIX expired on December 31, 2020, at which time HCVIX entered into liquidation. The process of liquidating HCVIX, including the distribution of marketable and non-marketable securities, has commenced in 2021, and HealthCare Partners IX, L.P. ("HCPIX"), the General Partner of HCVIX, as liquidator, will use its best efforts to complete the orderly liquidation of HCVIX. F2 · kind: These warrants were owned directly by HCVIX. Christopher K. Mirabelli, Douglas E. Onsi and Augustine Lawlor (collectively, the "HCVIX Directors") are the Managing Directors of HealthCare Partners IX, LLC ("HCPIX LLC"), which is the General Partner of HCPIX, which is the General Partner of HCVIX. Each of the HCVIX Directors, HCPIX LLC and HCPIX indirectly beneficially owns and shares voting and dispositive power with respect to all of the securities owned by HCVIX, and each disclaimed beneficial ownership of the warrants except to the extent of his or its proportionate pecuniary interest therein. F3 · kind: The warrants were acquired in connection with the purchase of an equal number of shares of common stock by the reporting persons on February 5, 2019 for $1.75 per share. Each such purchased share of common stock was issued with a warrant to purchase one share of common stock. HCVIX will continue to hold 4,144,804 shares of common stock following the Transfer. F3 · price: The warrants were acquired in connection with the purchase of an equal number of shares of common stock by the reporting persons on February 5, 2019 for $1.75 per share. Each such purchased share of common stock was issued with a warrant to purchase one share of common stock. HCVIX will continue to hold 4,144,804 shares of common stock following the Transfer. F2 · ownership.direct: These warrants were owned directly by HCVIX. Christopher K. Mirabelli, Douglas E. Onsi and Augustine Lawlor (collectively, the "HCVIX Directors") are the Managing Directors of HealthCare Partners IX, LLC ("HCPIX LLC"), which is the General Partner of HCPIX, which is the General Partner of HCVIX. Each of the HCVIX Directors, HCPIX LLC and HCPIX indirectly beneficially owns and shares voting and dispositive power with respect to all of the securities owned by HCVIX, and each disclaimed beneficial ownership of the warrants except to the extent of his or its proportionate pecuniary interest therein. Read SEC document |
| February 05, 2019 Filed Feb 5, 2019 16:19 UTC | CYPHERPUNK TECHNOLOGIES INC. LPTX · Entity 6392 | PurchaseWarrant (Right to Buy) · Derivative | 571,428 | Not disclosed Strike: $1.95 | Not disclosed |
DisclosureSEC source: 0001104659-19-005835 · a4.xml · derivative · entry 2 HealthCare Ventures IX, L.P. · CIK 0001490245 · 10% owner Healthcare Partners IX, L.P. · CIK 0001697027 · 10% owner Healthcare Partners IX, LLC · CIK 0001698828 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 571,428 Underlying: Common Stock, $0.001 par value per share · 571,428 shares Expires 2026-02-05 F2 · price: The reported securities were included with the 571,428 shares of common stock purchased by the reporting persons for $1.75 per share. Each such purchased share of common stock was issued with a warrant to purchase one share of common stock. F1 · ownership.direct: The shares are owned directly by HealthCare Ventures IX, L.P. Christopher K. Mirabelli, Douglas E. Onsi and Augustine Lawlor (collectively, the "HCVIX Directors") are the Managing Directors of HealthCare Partners IX, LLC ("HCPIX LLC"), which is the General Partner of HealthCare Partners IX, L.P. ("HCPIX"), which is the General Partner of HealthCare Ventures IX, L.P. Each of the HCVIX Directors, HCPIX LLC and HCPIX indirectly beneficially own and share voting and dispositive power with respect to all of the securities owned by HealthCare Ventures IX, L.P. and each disclaims beneficial ownership of these shares except to the extent of his or its proportionate pecuniary interest in these securities. Read SEC document |
| February 05, 2019 Filed Feb 5, 2019 16:19 UTC | CYPHERPUNK TECHNOLOGIES INC. LPTX · Entity 6392 | PurchaseCommon Stock | 571,428 | $1.75 | $999,999.00 |
DisclosureSEC source: 0001104659-19-005835 · a4.xml · nonDerivative · entry 1 HealthCare Ventures IX, L.P. · CIK 0001490245 · 10% owner Healthcare Partners IX, L.P. · CIK 0001697027 · 10% owner Healthcare Partners IX, LLC · CIK 0001698828 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,144,804 F1 · ownership.direct: The shares are owned directly by HealthCare Ventures IX, L.P. Christopher K. Mirabelli, Douglas E. Onsi and Augustine Lawlor (collectively, the "HCVIX Directors") are the Managing Directors of HealthCare Partners IX, LLC ("HCPIX LLC"), which is the General Partner of HealthCare Partners IX, L.P. ("HCPIX"), which is the General Partner of HealthCare Ventures IX, L.P. Each of the HCVIX Directors, HCPIX LLC and HCPIX indirectly beneficially own and share voting and dispositive power with respect to all of the securities owned by HealthCare Ventures IX, L.P. and each disclaims beneficial ownership of these shares except to the extent of his or its proportionate pecuniary interest in these securities. Read SEC document |
| July 30, 2018 Filed Aug 1, 2018 19:22 UTC | CYPHERPUNK TECHNOLOGIES INC. LPTX · Entity 6392 | OtherWarrant (Right to Buy) · Derivative | 1,057,769 | $0.00 Strike: $6.09 | $0.00 |
DisclosureSEC source: 0001104659-18-048864 · a4.xml · derivative · entry 1 HealthCare Ventures IX, L.P. · CIK 0001490245 · 10% owner Healthcare Partners IX, L.P. · CIK 0001697027 · 10% owner Healthcare Partners IX, LLC · CIK 0001698828 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,057,769 shares Expires 2024-11-14 F1 · kind: HealthCare Ventures IX, L.P. ("HCV IX") distributed these warrants to its limited partners on a pro rata basis, for no consideration. In the distribution, Eli Lilly and Company, a 5% or greater stockholder of the Company and limited partner of HCV IX, received a warrant to purchase 331,221 shares of common stock. No shares of outstanding common stock were distributed. HCV IX continues to hold 3,573,376 shares of common stock, which represents 24.3% of the outstanding common stock. Read SEC document |
| November 14, 2017 Filed Nov 16, 2017 13:45 UTC | CYPHERPUNK TECHNOLOGIES INC. LPTX · Entity 6392 | PurchaseWarrant (Right to Buy) · Derivative | 1,057,769 | Not disclosed Strike: $6.09 | Not disclosed |
DisclosureSEC source: 0001104659-17-069120 · a4.xml · derivative · entry 2 HealthCare Ventures IX, L.P. · CIK 0001490245 · 10% owner Healthcare Partners IX, L.P. · CIK 0001697027 · 10% owner Healthcare Partners IX, LLC · CIK 0001698828 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,057,769 Underlying: Common Stock, $0.001 par value per share · 1,057,769 shares Expires 2024-11-14 F2 · price: The reported securities were included with the 1,057,759 shares of common stock purchased by the reporting persons for $6.085 per share. Each such purchased share of common stock was issued with a warrant to purchase one share of common stock. F1 · ownership.direct: The shares are owned directly by HealthCare Ventures IX, L.P. Christopher K. Mirabelli, Douglas E. Onsi and Augustine Lawlor (collectively, the "HCVIX Directors") are the Managing Directors of HealthCare Partners IX, LLC ("HCPIX LLC"), which is the General Partner of HealthCare Partners IX, L.P. ("HCPIX"), which is the General Partner of HealthCare Ventures IX, L.P. Each of the HCVIX Directors, HCPIX LLC and HCPIX indirectly beneficially own and share voting and dispositive power with respect to all of the securities owned by HealthCare Ventures IX, L.P. and each disclaims beneficial ownership of these shares except to the extent of his or its proportionate pecuniary interest in these securities. Read SEC document |
| November 14, 2017 Filed Nov 16, 2017 13:45 UTC | CYPHERPUNK TECHNOLOGIES INC. LPTX · Entity 6392 | PurchaseCommon Stock | 1,057,769 | $6.09 | $6,436,524.37 |
DisclosureSEC source: 0001104659-17-069120 · a4.xml · nonDerivative · entry 1 HealthCare Ventures IX, L.P. · CIK 0001490245 · 10% owner Healthcare Partners IX, L.P. · CIK 0001697027 · 10% owner Healthcare Partners IX, LLC · CIK 0001698828 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,573,376 F1 · ownership.direct: The shares are owned directly by HealthCare Ventures IX, L.P. Christopher K. Mirabelli, Douglas E. Onsi and Augustine Lawlor (collectively, the "HCVIX Directors") are the Managing Directors of HealthCare Partners IX, LLC ("HCPIX LLC"), which is the General Partner of HealthCare Partners IX, L.P. ("HCPIX"), which is the General Partner of HealthCare Ventures IX, L.P. Each of the HCVIX Directors, HCPIX LLC and HCPIX indirectly beneficially own and share voting and dispositive power with respect to all of the securities owned by HealthCare Ventures IX, L.P. and each disclaims beneficial ownership of these shares except to the extent of his or its proportionate pecuniary interest in these securities. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.